Inventor · disambiguated record
Robert A. Lazarus
Also filed as: LAZARUS ROBERT A · LAZARUS Robert
36 granted patents·15 pending applications·1,401 citations·filing 1984–2023
98Inventor score
Top patents by PatentIndex Score
51 records- 0195US5786328AUse of kunitz type plasma kallikrein inhibitorsGENENTECH INC·Filed 1995·Granted Jul 28, 1998·149 cites·4 claims
- 0294US5874407AFactor VIIA inhibitorsGENENTECH INC·Filed 1997·Granted Feb 23, 1999·113 cites·4 claims
- 0393US7407785B2Human DNase I hyperactive variantsGENENTECH INC·Filed 2004·Granted Aug 5, 2008·34 cites·5 claims
- 0493US6348343B2Human DNase I variantsGENENTECH INC·Filed 2001·Granted Feb 19, 2002·48 cites·21 claims
- 0593US5780265AKunitz type plasma kallikrein inhibitorsGENENTECH INC·Filed 1995·Granted Jul 14, 1998·125 cites·11 claims
- 0693US5376544AEnzymes for the production of 2-keto-L-gulonic acidUNIV RUTGERS·Filed 1992·Granted Dec 27, 1994·52 cites·1 claims
- 0792US6391607B1Human DNase I hyperactive variantsGENENTECH INC·Filed 1996·Granted May 21, 2002·74 cites·10 claims
- 0892US6113896APharmaceutical compositions containing ecotin and homologs thereofGENENTECH INC·Filed 1994·Granted Sep 5, 2000·80 cites·9 claims
- 0992US4757012AAscorbic acid intermediates and process enzymesGENENTECH INC·Filed 1984·Granted Jul 12, 1988·48 cites·5 claims
- 1091US5880256AFactor VIIa inhibitors from Kunitz domain proteinsGENENTECH INC·Filed 1995·Granted Mar 9, 1999·75 cites·67 claims
- 1191US5834244AFactor VIIa inhibitors from Kunitz domain proteinsGENENTECH INC·Filed 1995·Granted Nov 10, 1998·82 cites·17 claims
- 1291US5032514AMetabolic pathway engineering to increase production of ascorbic acid intermediatesGENENTECH INC·Filed 1988·Granted Jul 16, 1991·76 cites·12 claims
- 1390US5843895APharmaceutical administration of ecotin homologsGENENTECH INC·Filed 1995·Granted Dec 1, 1998·64 cites·6 claims
- 1490US5795954AFactor VIIa inhibitors from Kunitz domain proteinsGENENTECH INC·Filed 1994·Granted Aug 18, 1998·81 cites·16 claims
- 1588US9453079B2Methods and compositions for neural disease immunotherapyGENENTECH INC·Filed 2014·Granted Sep 27, 2016·9 cites·35 claims
- 1688US5863893AFactor VIIa inhibitors from kunitz domain proteinsGENENTECH INC·Filed 1995·Granted Jan 26, 1999·66 cites·11 claims
- 1788US5719041ADNA encoding ecotin homologsGENENTECH INC·Filed 1995·Granted Feb 17, 1998·67 cites·9 claims
- 1886US7084109B2FVIIa antagonistsGENENTECH INC·Filed 2002·Granted Aug 1, 2006·27 cites·63 claims
- 1986US5736364AFactor viia inhibitorsGENENTECH INC·Filed 1995·Granted Apr 7, 1998·47 cites·21 claims
- 2080US7737115B2HGF beta chain variantsGENENTECH INC·Filed 2006·Granted Jun 15, 2010·3 cites·17 claims
- 2171US9193766B2Peptide inhibitors of BACE1GENENTECH INC·Filed 2012·Granted Nov 24, 2015·1 cites·16 claims
- 2271US2010040634A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2009·Application pending·0 cites
- 2370US5583025AEnzymes for the production of 2-keto-L-gulonic acidUNIV RUTGERS·Filed 1994·Granted Dec 10, 1996·26 cites·9 claims
- 2469US5912161AEnzymes for the production of 2-keto-L-gulonic acidUNIV RUTGERS·Filed 1996·Granted Jun 15, 1999·18 cites·16 claims
- 2568US5227469APlatelet aggregation inhibitors from the leechGENENTECH INC·Filed 1990·Granted Jul 13, 1993·33 cites·3 claims
- 2667US2019054138A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2018·Application pending·0 cites
- 2766US2008195366A1Crystal structure of the hepatocyte growth factor and methods of useEIGENBROT CHARLES W·Filed 2008·Application pending·0 cites
- 2866US2015126448A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2014·Application pending·0 cites
- 2966US2023416825A1Use of klk5 antagonists for the treatment of a diseaseGENENTECH INC·Filed 2023·Application pending·0 cites
- 3065US2008293121A1Human dnase i hyperactive variantsGENENTECH INC·Filed 2008·Application pending·0 cites
- 3164US10787484B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2018·Granted Sep 29, 2020·0 cites·73 claims
- 3264US8772457B2BACE1 antibodiesATWAL JASVINDER·Filed 2011·Granted Jul 8, 2014·1 cites·28 claims
- 3362US11034725B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2020·Granted Jun 15, 2021·0 cites·9 claims
- 3461US2017106042A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2016·Application pending·0 cites
- 3560US2006035278A9Methods and compositions for modulating HGF/MetGENENTECH INC·Filed 2004·Application pending·0 cites
- 3660US2007129301A1Methods and compositions for modulating hgf/metKIRCHHOFER DANIEL K·Filed 2006·Application pending·0 cites
- 3759US8623997B2Variant Hhip1 protein and methods and uses thereofBOSANAC IVAN·Filed 2009·Granted Jan 7, 2014·1 cites·16 claims
- 3858US2013143813A1Methods and compositions for modulating hgf/metKIRCHHOFER DANIEL K·Filed 2011·Application pending·0 cites
- 3958US2006003931A1Crystal structure of the hepatocyte growth factor and methods of useGENENTECH INC·Filed 2005·Application pending·0 cites
- 4058US2011177058A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2010·Application pending·0 cites
- 4155US9879094B2Nucleic acid molecules encoding for BACE1 antibodiesGENENTECH INC·Filed 2016·Granted Jan 30, 2018·0 cites·27 claims
- 4252US2002173025A1Human DNase I hyperactive variantsGENENTECH INC·Filed 2001·Application pending·0 cites
- 4350US9624269B2Peptide inhibitors of BACE1GENENTECH INC·Filed 2015·Granted Apr 18, 2017·0 cites·12 claims
- 4450US7164002B2FVIIa antagonistsGENENTECH INC·Filed 2003·Granted Jan 16, 2007·0 cites·27 claims
- 4548US8110377B2HGF β chain variantsKIRCHHOFER DANIEL K·Filed 2010·Granted Feb 7, 2012·0 cites·22 claims
- 4647US8623821B2Zymogen activatorsGENENTECH INC·Filed 2012·Granted Jan 7, 2014·0 cites·19 claims
- 4742US10562946B2Chagasin-based scaffold compositions, methods, and usesGENENTECH INC·Filed 2015·Granted Feb 18, 2020·0 cites·5 claims
- 4842US2019078160A1Use of klk5 antagonists for treatment of a diseaseGENENTECH INC·Filed 2018·Application pending·0 cites
- 4942US2006019893A1Factor VIIa variantsGENENTECH INC·Filed 2005·Application pending·0 cites
- 5039US10005848B2Method of reducing blood glucose by administering RON agonistsGENENTECH INC·Filed 2015·Granted Jun 26, 2018·0 cites·5 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →